Apollo Commercial Real Estate Finance, Inc. (ARI) - Q3 2025 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended September 30, 2025. Apollo Commercial Real Estate Finance, Inc. (ARI) is a Maryland corporation taxed as a Real Estate Investment Trust (REIT). The company originates, acquires, and manages performing commercial first mortgage loans, subordinate financings, and other commercial real estate-related debt investments. It is externally managed by ACREFI Management, LLC, an affiliate of Apollo Global Management, Inc.
Key Financial Metrics
| Metric | Q3 2025 (Three Months) | YTD 2025 (Nine Months) | YTD 2024 (Nine Months) |
|---|---|---|---|
| Total Net Revenue | $61.6 million | $198.3 million | $233.2 million |
| Net Interest Income | $40.0 million | $122.6 million | $155.5 million |
| Net Income (Loss) | $50.8 million | $97.5 million | ($160.3 million) |
| Net Income Available to Common Stockholders | $47.7 million | $88.3 million | ($169.5 million) |
| Diluted EPS (Common) | $0.34 | $0.62 | ($1.23) |
| Total Assets | $9.52 billion | vs. $8.41 billion (Dec 31, 2024) | |
| Total Liabilities | $7.66 billion | vs. $6.54 billion (Dec 31, 2024) | |
| Stockholders' Equity | $1.86 billion | vs. $1.87 billion (Dec 31, 2024) | |
| Cash and Cash Equivalents | $245.9 million | vs. $317.4 million (Dec 31, 2024) | |
| Loan Portfolio (Carrying Value, Net) | $8.30 billion | vs. $7.10 billion (Dec 31, 2024) | |
| Debt-to-Equity Ratio | 3.8x | vs. 3.2x (Dec 31, 2024) |
Material Changes vs. Prior Period
- Profitability Turnaround: The company reported a net income of $50.8 million for Q3 2025, a significant improvement from a net loss of $91.5 million in Q3 2024. This reversal is largely driven by a $17.4 million gain on a litigation settlement (Massachusetts Healthcare JV) and a reduction in realized losses on investments compared to the prior year.
- Portfolio Growth: The loan portfolio carrying value increased by approximately $1.2 billion year-over-year, driven by new fundings of $2.2 billion and add-on fundings of $701.5 million during the nine months ended September 30, 2025.
- Foreign Currency Impact: While Q3 2025 saw a $24.2 million gain on foreign currency forward contracts, the nine-month period included a $96.9 million loss on these contracts, partially offset by a $97.3 million foreign currency translation gain.
- Realized Losses: Net realized losses on investments decreased significantly to $7.4 million for the nine months ended September 30, 2025, compared to $128.2 million in the same period in 2024. The 2024 figure included a $127.5 million write-off related to the Massachusetts Healthcare Loan.
- Debt Structure: In June 2025, the company refinanced its 2026 and 2028 Term Loans with a new $750 million 2030 Term Loan. Secured debt arrangements increased to $5.9 billion from $4.8 billion at year-end 2024.
Guidance, Outlook, and Risks
- Dividends: The company declared a quarterly dividend of $0.25 per share of common stock and $0.45 per share of Series B-1 Preferred Stock. The board considers Distributable Earnings (a non-GAAP measure) in setting dividends.
- Liquidity: As of September 30, 2025, the company held $245.9 million in cash and had approximately $53.3 million in available borrowings under existing financing arrangements. It also holds $1.0 billion in unfunded loan commitments.
- Key Risks:
- Credit Risk: The portfolio includes 2 loans rated "5" (Impaired/Loss Likely) with a carrying value of $124.1 million. Specific CECL allowances remain significant at $335.0 million.
- Interest Rate Risk: The company is exposed to interest rate fluctuations, though it utilizes hedging instruments (interest rate caps and FX forwards) to mitigate this risk.
- Real Estate Owned (REO): The company owns three properties (D.C. Hotel, Brooklyn Multifamily, Atlanta Hotel). The Brooklyn Multifamily Development reached substantial completion in Q3 2025, leading to a cessation of expense capitalization for that component and a shift to depreciation.
- Unusual Items: The Q3 2025 results were materially impacted by a $17.4 million gain from a litigation settlement with the Commonwealth of Massachusetts regarding the St. Elizabeth's Medical Center taking. Additionally, a $6.2 million realized loss was recorded on the discounted payoff of the Michigan Office Loan.
Investor Verification Checklist
- Litigation Settlement Sustainability: Verify the one-time nature of the $17.4 million gain from the Massachusetts Healthcare litigation and its impact on Distributable Earnings vs. GAAP Net Income.
- Credit Quality of "Risk 5" Loans: Review the status of the two loans rated "5" (Cincinnati Retail and Manhattan Residential) totaling $124.1 million carrying value to assess potential future write-offs.
- Foreign Currency Hedging Effectiveness: Analyze the volatility in foreign currency gains/losses (e.g., $96.9M loss on forwards YTD 2025 vs. $29.8M loss YTD 2024) and the adequacy of hedging strategies.
- REO Performance: Monitor the operational performance of the three Real Estate Owned properties, particularly the transition of the Brooklyn Multifamily Development from construction to operations.
- Debt Maturity Profile: Confirm the company's ability to refinance or repay the $0.8 billion of secured debt arrangements maturing in the short term, given the current interest rate environment.